Glucagon-Like Peptide-1 Receptor Agonist Use in People Living with Type 2 Diabetes Mellitus and Chronic Kidney Disease: A Narrative Review of the Key Evidence with Practical Considerations

ABSTRACT: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are incretin-mimetic agents that are effective adjuncts in the treatment of diabetes. This class of medications is also associated with promoting weight loss and a low risk of hypoglycemia, and some have been shown to be associated with...

Descripción completa

Detalles Bibliográficos
Autores principales: Górriz, José L., Romera, Irene, Cobo, Amelia, O’Brien, Phillipe D., Merino-Torres, Juan F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8934828/
https://www.ncbi.nlm.nih.gov/pubmed/35175551
http://dx.doi.org/10.1007/s13300-021-01198-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8934828/
https://www.ncbi.nlm.nih.gov/pubmed/35175551
http://dx.doi.org/10.1007/s13300-021-01198-5

Ejemplares similares